Well you have to be impressed with these Norwegian guys. The way they have taken an observation relating to a different field of research (one on most researchers avoid list) and are running with it. Credit to those participants too. Not satisfied with the trial they are even conducting a genetic study of predisposition. Brilliant.
If their trial confirms that B cell depletion can bring remission in ME that will be big news. As we wait for these result to come, I hope that the planned US programs will take off and kick start the expansion of ME research. We really need to understand the pathology of our disease, to identify specific targets for therapy. For example, if Rituximab points to the potential of immunotherapy for ME and we have a clearer understanding of our immunopathology then therapies designed specifically for ME (and its subgroups) could be produced.
If their trial confirms that B cell depletion can bring remission in ME that will be big news. As we wait for these result to come, I hope that the planned US programs will take off and kick start the expansion of ME research. We really need to understand the pathology of our disease, to identify specific targets for therapy. For example, if Rituximab points to the potential of immunotherapy for ME and we have a clearer understanding of our immunopathology then therapies designed specifically for ME (and its subgroups) could be produced.